---
title: 'Smoking-independent DNA methylation markers for lung cancer risk: External
  validation in a large population-based cohort study'
date: '2024-12-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39624886/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241203172312&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Smoking-associated epigenetic changes have been linked to lung cancer
  (LC) risk; however, the role of epigenetic alterations independent of smoking is
  yet to be fully understood. This study aimed to validate 16 previously reported
  CpG sites that are independent of smoking yet associated with LC risk within a population-based
  prospective cohort. Using the Infinium Methylation EPIC BeadChip kit or the Infinium
  HumanMethylation450K BeadChip Assay, DNA methylation (DNAm) in whole blood was ...
disable_comments: true
---
Smoking-associated epigenetic changes have been linked to lung cancer (LC) risk; however, the role of epigenetic alterations independent of smoking is yet to be fully understood. This study aimed to validate 16 previously reported CpG sites that are independent of smoking yet associated with LC risk within a population-based prospective cohort. Using the Infinium Methylation EPIC BeadChip kit or the Infinium HumanMethylation450K BeadChip Assay, DNA methylation (DNAm) in whole blood was ...